Literature DB >> 18470542

Regulatory phosphorylation of cyclin-dependent kinase 2: insights from molecular dynamics simulations.

Iveta Bártová1, Jaroslav Koca, Michal Otyepka.   

Abstract

The structures of fully active cyclin-dependent kinase-2 (CDK2) complexed with ATP and peptide substrate, CDK2 after the catalytic reaction, and CDK2 inhibited by phosphorylation at Thr14/Tyr15 were studied using molecular dynamics (MD) simulations. The structural details of the CDK2 catalytic site and CDK2 substrate binding box were described. Comparison of MD simulations of inhibited complexes of CDK2 was used to help understand the role of inhibitory phosphorylation at Thr14/Tyr15. Phosphorylation at Thr14/Tyr15 causes ATP misalignment for the phosphate-group transfer, changes in the Mg(2+) coordination sphere, and changes in the H-bond network formed by CDK2 catalytic residues (Asp127, Lys129, Asn132). The inhibitory phosphorylation causes the G-loop to shift from the ATP binding site, which leads to opening of the CDK2 substrate binding box, thus probably weakening substrate binding. All these effects explain the decrease in kinase activity observed after inhibitory phosphorylation at Thr14/Tyr15 in the G-loop. Interaction of the peptide substrate, and the phosphorylated peptide product, with CDK2 was also studied and compared. These results broaden hypotheses drawn from our previous MD studies as to why a basic residue (Arg/Lys) is preferred at the P(+2) substrate position.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18470542     DOI: 10.1007/s00894-008-0312-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  30 in total

Review 1.  Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C.

Authors:  C G Takizawa; D O Morgan
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

Review 2.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 3.  Pharmacological inhibitors of cyclin-dependent kinases.

Authors:  Marie Knockaert; Paul Greengard; Laurent Meijer
Journal:  Trends Pharmacol Sci       Date:  2002-09       Impact factor: 14.819

4.  Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members.

Authors:  S K Hanks; A M Quinn
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 5.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

6.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.

Authors:  N R Brown; M E Noble; J A Endicott; L N Johnson
Journal:  Nat Cell Biol       Date:  1999-11       Impact factor: 28.824

7.  The mechanism of inhibition of the cyclin-dependent kinase-2 as revealed by the molecular dynamics study on the complex CDK2 with the peptide substrate HHASPRK.

Authors:  Iveta Bártová; Michal Otyepka; Zdenek Kríz; Jaroslav Koca
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

8.  Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism.

Authors:  A Cook; E D Lowe; E D Chrysina; V T Skamnaki; N G Oikonomakos; L N Johnson
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

9.  A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.

Authors:  J K Holmes; M J Solomon
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

10.  Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis.

Authors:  K L Gould; P Nurse
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

View more
  8 in total

1.  Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.

Authors:  Mingli Xiang; Yuchun Lin; Gu He; Lijuan Chen; Mingli Yang; Shengyong Yang; Yirong Mo
Journal:  J Mol Model       Date:  2012-06-27       Impact factor: 1.810

2.  Molecular cloning, sequence characterization and tissue transcription profile analyses of two novel genes: LCK and CDK2 from the Black-boned sheep (Ovis aries).

Authors:  Hongman Yu; Shanna Chen; Dongmei Xi; Yiduo He; Qin Liu; Huaming Mao; Weidong Deng
Journal:  Mol Biol Rep       Date:  2009-04-02       Impact factor: 2.316

3.  Novel phosphotyrosine targets of FGFR2IIIb signaling.

Authors:  Yongde Luo; Chaofeng Yang; Chengliu Jin; Rui Xie; Fen Wang; Wallace L McKeehan
Journal:  Cell Signal       Date:  2009-05-03       Impact factor: 4.315

4.  An acidic loop and cognate phosphorylation sites define a molecular switch that modulates ubiquitin charging activity in Cdc34-like enzymes.

Authors:  Elena Papaleo; Valeria Ranzani; Farida Tripodi; Alessandro Vitriolo; Claudia Cirulli; Piercarlo Fantucci; Lilia Alberghina; Marco Vanoni; Luca De Gioia; Paola Coccetti
Journal:  PLoS Comput Biol       Date:  2011-05-26       Impact factor: 4.475

5.  A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding.

Authors:  Emma S Child; Tereza Hendrychová; Karen McCague; Andy Futreal; Michal Otyepka; David J Mann
Journal:  Biochim Biophys Acta       Date:  2010-04-24

6.  The ERK-1 function is required for HSV-1-mediated G1/S progression in HEP-2 cells and contributes to virus growth.

Authors:  Ivana Colao; Rosamaria Pennisi; Assunta Venuti; Michaela Nygårdas; Outi Heikkilä; Veijo Hukkanen; Maria Teresa Sciortino
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

7.  Palbociclib can overcome mutations in cyclin dependent kinase 6 that break hydrogen bonds between the drug and the protein.

Authors:  Stella Hernandez Maganhi; Patrizia Jensen; Ignez Caracelli; Julio Zukerman Schpector; Stefan Fröhling; Ran Friedman
Journal:  Protein Sci       Date:  2017-03-06       Impact factor: 6.725

Review 8.  Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.

Authors:  Paul W Finch; Lawrence J Mark Cross; Daniel F McAuley; Catherine L Farrell
Journal:  J Cell Mol Med       Date:  2013-09       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.